458 related articles for article (PubMed ID: 11805437)
1. Risk factors and seroprevalence of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection in uzbekistan.
Ruzibakiev R; Kato H; Ueda R; Yuldasheva N; Hegay T; Avazova D; Kurbanov F; Zalalieva M; Tuichiev L; Achundjanov B; Mizokami M
Intervirology; 2001; 44(6):327-32. PubMed ID: 11805437
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of hepatitis B, hepatitis C, human immunodeficiency virus, Treponema pallidum, and co-infections among blood donors in Kyrgyzstan: a retrospective analysis (2013-2015).
Karabaev BB; Beisheeva NJ; Satybaldieva AB; Ismailova AD; Pessler F; Akmatov MK
Infect Dis Poverty; 2017 Feb; 6(1):45. PubMed ID: 28222792
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of HCV, HBV and HIV in two inner-city London emergency departments.
Cieply L; Simmons R; Ijaz S; Kara E; Rodger A; Rosenberg W; McGuinness A; Mbisa JL; Ledesma J; Ohemeng-Kumi N; Dicks S; Potts H; Lattimore S; Mandal S
Epidemiol Infect; 2019 Jan; 147():e145. PubMed ID: 30869036
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence and genotyping of hepatitis B, hepatitis C and HIV among healthy population and Turkish soldiers in Northern Cyprus.
Altindis M; Yilmaz S; Dikengil T; Acemoglu H; Hosoglu S
World J Gastroenterol; 2006 Nov; 12(42):6792-6. PubMed ID: 17106927
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B, Hepatitis C, and Human Immune deficiency Virus Seroconversion Positivity Rates and Their Potential Risk Factors Among Patients on Maintenance Hemodialysis in Cameroon.
Halle MP; Choukem SP; Kaze FF; Ashuntantang G; Tchamago V; Mboue-Djieka Y; Temfack E; Luma HN
Iran J Kidney Dis; 2016 Sep; 10(5):304-309. PubMed ID: 27721229
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria.
Egah DZ; Banwat EB; Audu ES; Iya D; Mandong BM; Anele AA; Gomwalk NE
East Mediterr Health J; 2007; 13(4):961-6. PubMed ID: 17955779
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of hepatitis B and C viruses and risk factors in HIV infected children at the Felgehiwot referral hospital, Ethiopia.
Abera B; Zenebe Y; Mulu W; Kibret M; Kahsu G
BMC Res Notes; 2014 Nov; 7():838. PubMed ID: 25421947
[TBL] [Abstract][Full Text] [Related]
9. An analysis on HBsAg, Anti-HCV, Anti-HIV½ and VDRL test results in blood donors according to gender, age range and years.
Eren C
PLoS One; 2019; 14(9):e0219709. PubMed ID: 31536507
[TBL] [Abstract][Full Text] [Related]
10. Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon.
Noubiap JJ; Joko WY; Nansseu JR; Tene UG; Siaka C
Int J Infect Dis; 2013 Oct; 17(10):e832-7. PubMed ID: 23317526
[TBL] [Abstract][Full Text] [Related]
11. Serological prevalence of hepatitis B virus and hepatitis C virus infection in the elderly population: Polish nationwide survey--PolSenior.
Hartleb M; Gutkowski K; Zejda JE; Chudek J; Więcek A
Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1288-95. PubMed ID: 22864260
[TBL] [Abstract][Full Text] [Related]
12. Seroepidemiology of HIV, syphilis and hepatitis B and C viruses among blood donors in Bangui, Central African Republic.
Nambei WS; Rawago-Mandjiza D; Gbangbangai E
Med Sante Trop; 2016 May; 26(2):192-8. PubMed ID: 27412978
[TBL] [Abstract][Full Text] [Related]
13. Triple positivity of HBsAg, anti-HCV antibody, and HIV and their influence on CD4+ lymphocyte levels in the highly HIV infected population of Abeokuta, Nigeria.
Ogwu-Richard SO; Ojo DA; Akingbade OA; Okonko IO
Afr Health Sci; 2015 Sep; 15(3):719-27. PubMed ID: 26957958
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of hepatitis B virus, hepatitis C virus, human immunodeficiency virus and Treponema pallidum infections in hospitalized patients before transfusion in Xiangya hospital Central South University, China from 2011 to 2016.
Cao WW; Zhou RR; Ou X; Shi LX; Xiao CQ; Chen TY; Tan H; Fan XG; Li BJ; Li N
BMC Infect Dis; 2018 Apr; 18(1):145. PubMed ID: 29606088
[TBL] [Abstract][Full Text] [Related]
15. Community seroprevalence of hepatitis B, C and human immunodeficiency virus in adult population in gojjam zones, northwest Ethiopia.
Abera B; Adem Y; Yimer M; Mulu W; Zenebe Y; Mekonnen Z
Virol J; 2017 Feb; 14(1):21. PubMed ID: 28166829
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of hepatitis B, hepatitis C, and HIV in pregnant women from Eastern Turkey.
Çınar Tanrıverdi E; Özkurt Z; Göktuğ Kadıoğlu B; Alay H; Çalıkoğlu O; Koca Ö; Kamalak Z
Turk J Gastroenterol; 2019 Mar; 30(3):260-265. PubMed ID: 30541714
[TBL] [Abstract][Full Text] [Related]
17. [HIVAb, HCVAb and HBsAg seroprevalence among inmates of the prison of Bologna and the effect of counselling on the compliance of proposed tests].
Sabbatani S; Giuliani R; Fulgaro C; Paolillo P; Baldi E; Chiodo F
Epidemiol Prev; 2004; 28(3):163-8. PubMed ID: 15532873
[TBL] [Abstract][Full Text] [Related]
18. [Seroprevalence of human immunodeficiency virus, hepatitis B virus and hepatitis C virus among blood donors in Segou, Mali].
Koné MC; Sidibé ET; Mallé KK; Beye SA; Lurton G; Dao S; Diarra MT; Dao S
Med Sante Trop; 2012; 22(1):97-8. PubMed ID: 22868738
[TBL] [Abstract][Full Text] [Related]
19. Epidemiological Profile and Risk Factors for Acquiring HBV and/or HCV in HIV-Infected Population Groups in Nepal.
Bhattarai M; Baniya JB; Aryal N; Shrestha B; Rauniyar R; Adhikari A; Koirala P; Oli PK; Pandit RD; Stein DA; Gupta BP
Biomed Res Int; 2018; 2018():9241679. PubMed ID: 29487874
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of HBV, HCV, and HIV and Associated Risk Factors Among Apparently Healthy Pregnant Women in Anyigba, Nigeria.
Omatola CA; Lawal C; Omosayin DO; Okolo MO; Adaji DM; Mofolorunsho CK; Bello KE
Viral Immunol; 2019 May; 32(4):186-191. PubMed ID: 31021251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
